Jacob Sten Petersen

Jacob Petersen has a vast experience in the pharmaceutical industry, holding positions such as Senior Vice President at Novo Nordisk. Jacob is also currently serving as a Member Board of Directors at Novo Nordisk Pharmatech A/S. Additionally, Jacob has held leadership roles at various organizations such as Chairman of the Board of Ketotic Hypoglycemia International. With a background in biochemistry and immunology, Jacob has contributed significantly to research and development in areas such as diabetes therapy and stem cell platforms for chronic diseases.